| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $102.2M | +45.8% |
| Cost of Revenue | $92.2M | +32.1% |
| Gross Profit | $10.0M | +2898.5% |
| R&D Expense | $32.4M | +1.8% |
| SG&A Expense | $52.4M | -6.5% |
| Operating Income | -$107.1M | -3.4% |
| Interest Expense | $5.1M | +19.2% |
| Pre-tax Income | -$107.3M | +2.5% |
| Income Tax | $0 | — |
| Net Income | -$107.3M | +2.5% |
| EPS (Basic) | -$0.59 | +11.9% |
| EPS (Diluted) | -$0.59 | +11.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $136.0M | -37.7% |
| Accounts Receivable | $41.4M | +91.1% |
| Inventory | $31.3M | +5.7% |
| Current Assets | $228.4M | -19.5% |
| Total Assets | $271.4M | -15.7% |
| Current Liabilities | $96.6M | +26.7% |
| Long-term Debt | $73.3M | +35.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$91.7M | -47.7% |
| Capital Expenditures | $3.9M | +150.0% |
| Investing Cash Flow | -$3.9M | -150.0% |
| Financing Cash Flow | $18.3M | -85.4% |
| Free Cash Flow | -$95.6M | -50.2% |
| Total Liabilities |
| $189.2M |
| +24.4% |
| Stockholders' Equity | $82.2M | -51.6% |